Gregoire Pierre Prevost
Overview
Explore the profile of Gregoire Pierre Prevost including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frongia C, Lorenzo C, Gianni F, Prevost G, Ducommun B, Lobjois V
Cancer Biol Ther
. 2009 Oct;
8(23):2230-36.
PMID: 19823027
Multicellular tumor spheroids closely mimic the 3D organization of avascular microregions within tumors and thereby represent a valuable model for the evaluation of anticancer drugs. In this study, we performed...
2.
Ayoub M, Damian M, Gespach C, Ferrandis E, Lavergne O, de Wever O, et al.
J Biol Chem
. 2009 Aug;
284(42):29136-45.
PMID: 19648112
The simultaneous activation of many distinct G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play a major role in various pathological conditions. Pan-inhibition of GPCR signaling by small molecules thus...
3.
4.
Brezak M, Valette A, Quaranta M, Contour-Galcera M, Jullien D, Lavergne O, et al.
Int J Cancer
. 2008 Dec;
124(6):1449-56.
PMID: 19065668
CDC25 phosphatases are key actors in cyclin-dependent kinases activation whose role is essential at various stages of the cell cycle. CDC25 expression is upregulated in a number of human cancers....
5.
Prevost G, Brezak M, Goubin F, Mondesert O, Galcera M, Quaranta M, et al.
Prog Cell Cycle Res
. 2003 Nov;
5:225-34.
PMID: 14593717
As essential cell cycle regulators, the CDC25 phosphatases are currently considered as potential targets for the development of novel therapeutic approaches. Here, we review the function and regulation of CDC25...